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Abstract

Driss Raissi, Qian Yu, S. Houssam Mardini1

Endoscopic intervention is well validated for the control of upper gastrointestinal
bleeding (UGIB). In cases of refractory bleeding, transarterial embolization is a
safe and effective alternative. Ethylene vinyl alcohol (EVOH) commonly known
as Onyx® is an inherently black liquid embolic approved for use in cerebrovascular
arteriovenous malformations and is increasingly used as an embolic agent in
multiple peripheral and visceral territories. Onyx® has a uniquely undesirable
property of causing black color discoloration when used in peripheral applications
adjacent to the skin akin to a “tattoo effect.” Knowledge of the agents used by
the interventional radiologist, clinical correlation, and close follow‑up can be of
paramount importance to avoid unnecessary surgical intervention. Here, we report
a case demonstrating this “tattoo effect” on the gastric mucosa following UGIB
embolization.
Keywords: Embolization, ethylene vinyl alcohol, Onyx, right gastric artery,
tattoo, upper gastrointestinal bleeding

Introduction

E

ndoscopic intervention is well validated for the
control of upper gastrointestinal bleeding (UGIB).
In cases of refractory bleeding, transarterial
embolization (TAE) is a safe and effective alternative.
Ethylene vinyl alcohol (EVOH) also known as
Onyx® (Covidien/ev3, Irvine, CA, USA) is an inherently
black liquid embolic approved for use in cerebrovascular
arteriovenous malformations and is increasingly used
as an embolic agent in multiple peripheral and visceral
territories including the gastrointestinal (GI) tract. It is
less adhesive than other liquid embolics such as N‑butyl
cyanoacrylate and polymerizes slowly, which provides
better control for the interventionalist performing the
procedure. However, Onyx® has a uniquely undesirable
property of causing black color discoloration when used
in peripheral applications adjacent to the skin.[1] This
side effect can be described as a skin “tattoo effect”
and should be discussed with the patient beforehand.
This “tattoo effect” can be easily confused with
gastric mucosal necrosis by the endoscopist during any
follow‑up endoscopy after UGIB embolization as the
“tattoo effect” may be permanent based on described
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skin findings in the literature.[1] Knowledge of the
agents used by the interventional radiologist, clinical
correlation, and close follow‑up can be of paramount
importance to avoid unnecessary surgical intervention.

Case Report
A 43‑year‑old male was referred to interventional
radiology after being admitted for decompensated
cirrhosis and persistent UGIB following endoscopic
therapy. The patient had a history of alcoholic cirrhosis,
portal hypertensive gastropathy, and gastric antral
vascular ectasia. He was admitted 1 year prior for
UGIB and underwent gastroduodenal artery (GDA) coil
embolization and supraduodenal artery pseudoaneurysm
N‑butyl cyanoacrylate embolization [Figure 1]. During
the current admission, the patient was hypotensive,
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Figure 1: A 43‑year‑old male with a history of alcoholic cirrhosis,
portal hypertensive gastropathy, and gastric antral vascular ectasia was
admitted 1 year ago for upper gastrointestinal bleeding. Digital subtracted
angiography of the celiac artery demonstrates previously coil‑embolized
GDA (blue arrow) and N‑butyl‑cyanoacrylate embolized supraduodenal
artery pseudoaneurysm (white arrow). Hemoclips from prior endoscopic
intervention were also visualized (green arrow). The RGA could be
visualized supplying the site of bleeding along the lesser curvature of
the stomach (red arrow).

and laboratory values were significant for low
hemoglobin and hematocrit level. Upper GI endoscopy
was performed showing large amount of blood in
the stomach with arterial bleeding after clot removal
at the prepyloric region just proximal to the pyloric
sphincter [Figure 2]. Endoscopy report suggested
underlying Dieulafoy lesion which was treated with
endoscopic hemoclips and epinephrine injection,
however, this failed to control the bleeding, which was
identified around the prepyloric region. Angiography
localized the bleeding to the right gastric artery (RGA)
territory with subsequent embolization of the RGA
branches using Onyx® (Covidien/ev3, Irvine, CA, USA)
liquid embolic system [Figure 3]. The patient underwent
a follow‑up endoscopy 24 h later which showed
mucosal changes in the expected anatomical distribution
of the embolized area consisting of black discoloration
but with no ulceration or bleeding. The endoscopist
impression was “ischemia with possible gastric
necrosis.” The patient remained hemodynamically stable
with no further evidence of bleeding, he had a benign
abdominal examination, and there was no clinical
evidence of gastric necrosis/ischemia or infection. The
case was discussed in a multidisciplinary conference that
included surgery, gastroenterology, and interventional
radiology. It was concluded that the mucosal changes
were due to staining of the mucosa with the agent used
for embolization Onyx® rather than gastric necrosis and
no further interventions were needed given the lack of
any concerning clinical signs in the patient.
2
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Figure 2: A 43‑year‑old‑male with a history of alcoholic cirrhosis, portal
hypertensive gastropathy, and gastric antral vascular ectasia was admitted for
recurrent upper gastrointestinal bleeding. Upper endoscopy shows ongoing
hemorrhage emanating from the prepyloric region toward the pylorus.

Discussion
Endoscopic hemostasis is the best first‑line treatment
in acute UGIB due to its ability to directly visualize
and characterize the site of bleeding.[2] In a situation
where endoscopy fails to control the bleeding, TAE
is considered a safer alternative to surgery, especially
in high‑risk patients with hemodynamic instability or
multiple comorbidities. TAE has a high technical and
clinical success rate based on several studies.[3‑5] In
our case, the patient experienced refractory bleeding
despite endoscopic interventions with hemoclips and
epinephrine injection. The patient’s hypotension and
multiple medical comorbidities made him a poor surgical
candidate, making TAE his best alternative.
While the left gastric and gastroduodenal arteries are
the most common culprits of UBGI,[4] less common
arterial branches must be considered, especially in the
setting of postsurgical or postembolization anatomy
such as patients after a Whipple’s procedure, prior
gastric surgery or a previous GDA embolization such
as in our case. Given that the GDA is either ligated or
embolized, these patients often rely on the RGA or the
left gastroepiploic artery to supply the distal portion of
their stomach. Thus, these vessels must be interrogated
during angiography in the aforementioned settings.
In our case, angiography of the RGA, which typically
supplies the distal third of the lesser gastric curvature,
demonstrated ongoing hemorrhage. Arterial embolization
of the RGA resulted in effective control of the patient’s
UGIB. Potential embolic agents that may be used for
the control of UGIB include both permanent materials
such as metallic coils and polyvinyl alcohol particles
as well as temporary ones like gelatin sponge particles.
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Figure 4: A 43‑year‑old male with a history of alcoholic cirrhosis, portal
hypertensive gastropathy, and gastric antral vascular ectasia was admitted
for recurrent upper gastrointestinal bleeding. Embolization of the right
gastric artery branches with Onyx®. Figure a and b – Upper endoscopy
demonstrating black staining/discoloration of the mucosa in the prepyloric
region with relatively normal surrounding gastric mucosa (yellow) next
to hemoclips (blue arrows).
Figure 3: A 43‑year‑old‑male with a history of alcoholic cirrhosis, portal
hypertensive gastropathy, and gastric antral vascular ectasia was admitted
for recurrent upper gastrointestinal bleeding. Embolization of the right
gastric artery branches with Onyx®. Postembolization fluoroscopic image
demonstrates Onyx® cast material within the embolized right gastric
branches (yellow arrows).

However, these agents may not be an option due to
anatomical and technical challenges.[6] In our case, the
bleeding arose from the distal branches of the RGA with
a suggested Dieulafoy/vascular lesion on angiography,
so Onyx® was selected as the embolic agent for its
ability to provide deep occlusion of distal branches and
obliterate anomalous vessels.[7]
Onyx® (Covidien/ev3, Irvine, CA, USA) is a nonadhesive
embolic agent comprised of EVOH copolymer dissolved
in dimethyl sulfoxide and suspended in micronized
tantalum powder to provide radiographic contrast for
visualization under fluoroscopy. The FDA approved
its use for brain arteriovenous malformations in July
2005. Onyx is available in two product formulations:
Onyx® 18 (Covidien/ev3, Irvine, CA, USA) and Onyx®
34 (Covidien/ev3, Irvine, CA, USA). Onyx 18 may
offer the advantage of deeper penetration into the nidus
due to its lower viscosity compared to Onyx 34. Final
solidification occurs within 5 min for both product
formulations making its delivery much more predictable
than other liquid embolics such as N‑butyl cyanoacrylate.
Direct endoscopic delivery of Onyx in the GI tract has
also been reported in one single case report.[8]
Although long‑term follow‑up is limited, this agent
appears to offer several advantages over the other
available embolic agents for the endovascular
management of arteriovenous malformations and
other vascular lesions. Onyx has shown positive
outcomes in controlling acute v bleeding in selected
patients with good results in long‑term follow‑up.[7]
Onyx is intrinsically black, and it is known to cause
staining of the overlying skin when used in peripheral

applications.[7,9] A similar “tattoo effect” finding was
incidentally observed in our patient’s gastric mucosa
during follow‑up endoscopy the next day [Figure 4].
This black color “tattoo effect” on the gastric mucosa
should not be confused with gastric necrosis when
performing endoscopy, especially in patients with a
history of arterial embolization with Onyx. Gastric
necrosis manifests itself with ominous clinical signs
leading to an acute abdomen with significant clinical
deterioration associated with the diagnosis.[10,11] While
esophageal necrosis also known as the “black esophagus”
is a well‑known entity,[12] endoscopic findings of gastric
mucosal necrosis have been mainly described in case
reports. Necrotic gastric mucosa typically demonstrates
thickened folds, exudative mucosa with or without
ulcerations in the setting of a clinically decompensating
patient and black mucosal discoloration may or may not
be part of the constellation of findings.[13‑15] In addition
and based on Onyx’s reported skin effects, the changes
attributed to this embolic material may be permanent
in the GI tract as well[7,9] and may prompt unnecessary
work‑up if not considered by the endoscopist at any
point in time during future endoscopies. To the best of
our knowledge, this is the first report to describe gastric
mucosa “tattoo effect” resulting from mucosal staining
after UGIB embolization with Onyx liquid embolic
system.

Conclusion
Endoscopy is the first‑line treatment for acute UGIB.
As a second line of treatment, TAE offers a safe and
effective option to control UGIB. Knowledge of the
embolic agents used by the interventional radiologist,
clinical correlation, and close follow‑up can be of
paramount importance to avoid unnecessary surgical
intervention. This finding on endoscopy supports the
need for the endoscopist to recognize mucosal changes
resulting from the use of specific embolic agents and
to have close communication with the interventional
Journal of Clinical Imaging Science ¦ Volume 8 ¦ 2018
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radiologist while working in a multidisciplinary
fashion. Furthermore, this gastric mucosa “tattoo
effect” secondary to embolization with Onyx maybe
permanent and unfamiliarity with this agent may prompt
unnecessary sampling and/or imaging studies if these
patients undergo any future upper endoscopy.
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